期刊文献+

Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection 被引量:8

下载PDF
导出
摘要 BACKGROUND Metabolic associated fatty liver disease(MAFLD)is a novel concept proposed in 2020.AIM To compare the characteristics of MAFLD and MAFLD with hepatitis B virus(HBV)infection.METHODS Patients with histopathologically proven MAFLD from a single medical center were included.Patients were divided into MAFLD group(without HBV infection)and HBV-MAFLD group(with HBV infection).Propensity score matching was utilized to balance the baseline characteristics between two groups.RESULTS A total of 417 cases with MAFLD were included,359(86.1%)of whom were infected with HBV.There were significantly more males in the HBV-MAFLD group than in the MAFLD group(P<0.05).After propensity score matching,58 pairs were successfully matched with no significant differences found in gender,age,body mass index,lipid levels,liver enzymes,and the other metabolic associated comorbidities between the two groups(P>0.05).The rank sum test results showed that the degree of liver steatosis in the MAFLD group was more severe than that in the HBV-MAFLD group,while the degree of inflammation and fibrosis in the liver was less severe(P<0.05).In multivariate analysis,HBV infection was associated with significantly lower grade of hepatic steatosis[odds ratio(OR)=0.088,95%confidence interval(CI):0.027-0.291]but higher inflammation level(OR=4.059,95%CI:1.403-11.742)and fibrosis level(OR=3.016,95%CI:1.087-8.370)after adjusting for age,gender,and other metabolic parameters.CONCLUSION HBV infection is associated with similar metabolic risks,lower steatosis grade,higher inflammation,and fibrosis grade in MAFLD patients.
出处 《World Journal of Gastroenterology》 SCIE CAS 2021年第4期336-344,共9页 世界胃肠病学杂志(英文版)
基金 Supported by Chinese National 13th Five-Year Plan's Science and Technology Projects,No.2017ZX10202201.
  • 相关文献

参考文献1

二级参考文献20

  • 1World Health Organization.Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. Journal of Viral Hepatitis . 1999
  • 2Christopher D. Williams,Joel Stengel,Michael I. Asike,Dawn M. Torres,Janet Shaw,Maricela Contreras,Cristy L. Landt,Stephen A. Harrison.Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study[J].Gastroenterology.2011(1)
  • 3David A. Sheridan,R. Dermot G. Neely,Margaret F. Bassendine.Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs)[J].Clinics and Research in Hepatology and Gastroenterology.2012
  • 4M. F. Bassendine,D. A. Sheridan,S. H. Bridge,D. J. Felmlee,R. D. G. Neely.Lipids and HCV[J].Seminars in Immunopathology.2013(1)
  • 5Ludwig J,Viggiano TR,McGill DB,et al.Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings . 1980
  • 6Tatsuo Kanda,Fumio Imazeki,Osamu Yokosuka.New antiviral therapies for chronic hepatitis C[J]. Hepatology International . 2010 (3)
  • 7Hwang SJ,Luo JC,Chu CW,Lai CR,Lu CL,Tsay SH,Wu JC,Chang FY,Lee SD.Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gas- troenterol Hepatol . 2001
  • 8J.-F. Li,F. Qu,S.-J. Zheng,H.-L. Wu,M. Liu,S. Liu,Y. Ren,F. Ren,Y. Chen,Z.-P. Duan,J.-L. Zhang.Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection[J]. European Journal of Clinical Microbiology & Infectious Diseases . 2014 (10)
  • 9Simon H. Bridge,David A. Sheridan,Daniel J. Felmlee,Mary M.E. Crossey,Fiona I. Fenwick,Clare V. Lanyon,Geneviève Dubuc,Nabil G. Seidah,Jean Davignon,Howard C. Thomas,Simon D. Taylor-Robinson,Geoffrey L. Toms,R. Dermot G. Neely,Margaret F. Bassendine.PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism[J]. Journal of Hepatology . 2014
  • 10Stergios A. Polyzos,Christos S. Mantzoros.Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease[J]. Metabolism . 2013

共引文献19

同被引文献43

引证文献8

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部